Skip to content
Search

Latest Stories

Mylan's US-labelled EpiPen 0.3mg adrenaline auto-injectors now available in UK

Pharmaceutical giant Mylan has released a batch of US-labelled auto-injectors in the UK to ensure patients have continuous access to Epipen 0.3mg.

The auto-injectors with the batch number 9FM766 have been approved by the UK regulator, Medicines and Health Regulatory Agency (MHRA).


The company website states that pharmacies are able to place orders and hold stock of EpiPen Jr 0.15mg and EpiPen 0.3mg AAI devices so that patient prescriptions can be fulfilled the same day.

The EpiPen auto-injectors in batch number is 9FM766) are affixed with a US label, and are packaged (as single packs) into UK cartons along with UK patient information leaflets.

The drug name is epinephrine in the US but is known as adrenaline in the UK. “Patients and carers familiar with the term adrenaline may be confused,” the company has warned.

 “The auto-injector device in this batch is exactly the same as the normal UK EpiPen in every way except for the information on the label on the device,” it added.

Other differences between the US-labelled and UK-labelled auto-injectors are:

  • The UK label has the instruction to ‘Dial 999, ask for ambulance and state ‘anaphylaxis!’, which is replaced with ‘Get emergency medical help!’ on the US label.
  • The warning ‘Keep of the reach and sight of children’ is omitted on the US auto-injector label. However, the UK carton and patient information leaflet include this statement.

The label on the EpiPen (epinephrine) auto-injector is meant for the US. Therefore, patients and carers should read the outer carton and enclosed patient information leaflet which is designed for UK patients.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less